Gmex is a pioneering Korean startup specializing in the development of medical therapeutics. The company’s product lineup includes innovative treatments for atopic dermatitis, cancer, leukemia, neuropathy, and pain management, as well as cervical cancer prevention. Leveraging natural substances and advanced medical device development, GMEX is dedicated to improving patient care and outcomes.

Vision: To be a leader in the medical field by providing advanced therapeutic solutions that enhance the quality of life for patients worldwide.

Mission: To continuously innovate and develop high-quality medical treatments and devices that address unmet medical needs and contribute to global health.

Noteworthy: GMEX is recognized for its commitment to research and development, particularly in the area of atopic treatment, and has established itself within the biotech and medical research community.

For the GICS industry group, GMEX would likely fall under the Health Care sector, specifically within the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Business Pitch: “Revolutionizing patient care with cutting-edge therapeutics for a healthier tomorrow—GMEX, your partner in medical innovation.”